These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38416455)
41. Rapid and sustained response to apremilast in a patient with long-standing acrodermatitis continua of Hallopeau. Fusta-Novell X; Esquius M; Creus-Vila L Dermatol Online J; 2022 Dec; 28(6):. PubMed ID: 36809102 [No Abstract] [Full Text] [Related]
43. Secukinumab for Acrodermatitis Continua of Hallopeau. Muggli D; Maul JT; Anzengruber F; Fopp MW; Navarini AA JAMA Dermatol; 2017 Apr; 153(4):336-337. PubMed ID: 28122071 [No Abstract] [Full Text] [Related]
44. Acrodermatitis continua of Hallopeau: was it an outcome of a surgical trauma or initially misdiagnosed as onychomycosis? Sahin MT; Oztürkcan S; Türel A; Kandiloğlu AR J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):236-8. PubMed ID: 12705767 [No Abstract] [Full Text] [Related]
45. An infant with acrodermatitis continua of Hallopeau: successful treatment with thalidomide and UVB therapy. Kiszewski AE; De Villa D; Scheibel I; Ricachnevsky N Pediatr Dermatol; 2009; 26(1):105-6. PubMed ID: 19250426 [TBL] [Abstract][Full Text] [Related]
46. Acrodermatitis continua of hallopeau successfully treated with adalimumab. Sopkovich JA; Anetakis Poulos G; Wong HK J Clin Aesthet Dermatol; 2012 Feb; 5(2):60-2. PubMed ID: 22468174 [TBL] [Abstract][Full Text] [Related]
47. Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents. Adışen E; Özer İ; Temel B; Gürer MA Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28139054 [TBL] [Abstract][Full Text] [Related]
49. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin. Tobin AM; Kirby B Br J Dermatol; 2005 Aug; 153(2):445-6. PubMed ID: 16086767 [No Abstract] [Full Text] [Related]
50. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review. Puig L; Barco D; Vilarrasa E; Alomar A Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631 [TBL] [Abstract][Full Text] [Related]
51. Acrodermatitis continua of Hallopeau with insufficient response to ixekizumab and infliximab, successfully treated with a combination of ustekinumab and tofacitinib. Chen X; Huang X; Ma L; Wang B; Tian J; Liu X Eur J Dermatol; 2023 Apr; 33(2):182-183. PubMed ID: 37431132 [No Abstract] [Full Text] [Related]
56. Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau. Caputo F; Parro S; Zoli G J Crohns Colitis; 2011 Dec; 5(6):649. PubMed ID: 22115391 [No Abstract] [Full Text] [Related]
57. Successful treatment of acrodermatitis continua of Hallopeau with sequential combination of calcipotriol and tacrolimus ointments. Brill TJ; Elshorst-Schmidt T; Valesky EM; Kaufmann R; Thaçi D Dermatology; 2005; 211(4):351-5. PubMed ID: 16286746 [TBL] [Abstract][Full Text] [Related]
58. Treatment of Recalcitrant Acrodermatitis Continua of Hallopeau With Brodalumab. Milani-Nejad N; Kaffenberger J J Drugs Dermatol; 2019 Oct; 18(10):1047. PubMed ID: 31603633 [TBL] [Abstract][Full Text] [Related]
59. Pustular psoriasis and acrodermatitis continua (Hallopeau) need high doses of systemic ciclosporin A. Korstanje MJ; Bessems PJ; Hulsmans RF; van de Staak WJ Dermatologica; 1989; 179(2):90-1. PubMed ID: 2792497 [No Abstract] [Full Text] [Related]
60. Three cases of Chen YL; Wang ZY; Ma L; Xu ZG Indian J Dermatol Venereol Leprol; 2020; 86(5):562-565. PubMed ID: 32769301 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]